FIELD: pharmacy. SUBSTANCE: proposed agent has 2-(2-fluoro-4-biphenylyl)-propionic acid as a free form or as pharmacologically toleratable salt and if necessary acceptable carriers and additional agents. In the case of pain or state at dominating pain content of R-(-)-enantiomer of 2-(2-fluoro-4-biphenylyl)-propionic acid is 60-99.5% and other - S-(+)-enantiomer; in the case of inflammation and chronic disease at dominating inflammation content of S-(+)-enantiomer is 60-99.5% and other - R-(-)-enantiomer. EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| EMPLOYMENT OF (R)-ARYLPROPIONIC ACIDS TO PREPARE DRUGS FOR TREATMENT OF HUMANS AND ANIMALS LIABLE TO BE THERAPEUTICALLY AFFECTED VIA NF-κB ACTIVATION INHIBITION | 2000 |
|
RU2250103C2 |
| IBUPROFEN THIOETHER AS INHIBITOR DEPENDING UPON NF-KB FORMATION OF INFLAMMATION AND PAIN MEDIATORS | 1998 |
|
RU2204388C2 |
| (S)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695647C2 |
| (R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695607C2 |
| COMPOSITION CONTAINING NSAID AND PARACETAMOL | 2006 |
|
RU2438656C2 |
| N-ACETYLCYSTEINE-CONTAINING COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS AND TOXICITY OF DRUGS | 2002 |
|
RU2291689C2 |
| PHARMACEUTICAL COMBINATION FOR PAIN TREATMENT | 2011 |
|
RU2589692C2 |
| ANALGETIC COMPOSITIONS CONTAINING NON-NARCOTIC ANALGETIC AND ENHANCER OF ANALGESIA | 1995 |
|
RU2213561C2 |
| PHARMACEUTICAL COMBINATION FOR PAIN TREATMENT | 2016 |
|
RU2675261C2 |
| PHARMACEUTICAL COMBINATION AND USING IT | 2011 |
|
RU2575775C2 |
